18 June 2013
Keywords: genzyme, extends, offer, anormed, biotechnology, group, says
Article | 06 November 2006
US biotechnology group Genzyme says that it has extended its offer to acquire the outstanding shares of AnorMED of Vancouver, ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.